Hikma Pharmaceuticals Usa Inc was founded in 2011 and operates in Eatontown, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC ...

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Hikma’s US subsidiary, West-Ward Pharmaceuticals ... In its injectables business, Hikma said a good mix of products will generate operating profit margins of 39%, up from the 38% previously ...

Hikma Pharmaceuticals will acquire parts of Danish ... The acquisition will add eight approved and marketed injectable ...

Hikma Pharmaceuticals PLC ... including a commercial portfolio and pipeline of differentiated products, the company said in the news release. Hikma's U.S. headquarters are in Berkley Heights ...

The company also reiterated guidance for its Branded business of revenue in the high-single digits, or 6% to 8% higher year-on-year, with a core operating margin around 25%. Its Generics business is ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Under the terms of the licensing agreement, Hikma will be responsible for the registration and commercialisation of the product in all MENA markets and Sun Pharma will be responsible for product ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.